کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5738054 1615037 2018 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Research articleLysophosphatidic acid propagates post-injury Schwann cell dedifferentiation through LPA1 signaling
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی علوم اعصاب (عمومی)
پیش نمایش صفحه اول مقاله
Research articleLysophosphatidic acid propagates post-injury Schwann cell dedifferentiation through LPA1 signaling
چکیده انگلیسی


- Lysophosphatidic acid (LPA) induces demyelination and Schwann cell (SC) dedifferentiation in DRG cultures.
- LPA mediated effects can be blocked by a LPA1 receptor antagonist (AM095).
- After sciatic nerve injury, AM095 treatment reduces SC dedifferentiation.
- LPA may contribute to the emergence of a post-injury SC phenotype.

Lysophosphatidic acid (LPA) is a pleiotropic signaling lipid that acts as ligand for at least six specific G-protein coupled receptors. Schwann cells (SC) are known to mainly express the LPA1 receptor subtype. An emerging body of evidence has linked LPA with injury-induced peripheral nerve demyelination as well as neuropathic pain. However, the molecular mechanisms underlying its demyelinating effect have not been conclusively elucidated.We aimed to decipher the demyelinating effect in vitro as well as in vivo by studying markers of SC differentiation and dedifferentiation: Myelinated dorsal root ganglia (DRG) cultures were treated either with LPA, LPA plus AM095 (LPA1 antagonist) or vehicle. Myelin content was subsequently investigated by Sudan Black staining and immunocytochemistry. In vivo, we performed sciatic nerve crush in C57BL/6 mice treated with AM095 at 10 mg/kg.In DRG cultures, LPA caused a significant reduction of myelin as demonstrated by both Sudan Black staining and immunocytochemical analysis of myelin basic protein. Demyelination was paralleled by an upregulation of TNF-alpha as well as downregulation of Sox10, a marker for SC differentiation. LPA mediated effects were largely blocked by the addition of the LPA1 receptor antagonist AM095. In the in vivo model, AM095 treatment prior to crush injury increased Sox10 expression in SCs in the distal nerve stump while reducing the number of cells expressing the SC dedifferentiation marker Sox2. Additionally, TNF-alpha immunofluorescence was reduced in CD11b-positive cells. These data indicate that LPA may be a critical factor that shifts SCs towards a post-injury phenotype and contributes to the onset of Wallerian degeneration.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Neuroscience Letters - Volume 662, 1 January 2018, Pages 136-141
نویسندگان
, , , , , ,